Mount Farm Surgery, Suffolk Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2010
NCT01217112
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Mount Farm Surgery | Mount Farm Surgery, Lawson Place, Bury St Edmunds, Suffolk, IP32 7EW

Active Ingredients

Drugs in Phase 2 Trials (2)

cannabidiol (Epidiolex) (1 trial)

tetrahydrocannabivarin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Dyslipidemias (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2